Literature DB >> 19734862

Boosting our best shot.

Charlotte Schubert1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19734862     DOI： 10.1038/nm0909-984

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  7 in total

1.  Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults.

Authors:  Scott A Halperin; Simon Dobson; Shelly McNeil; Joanne M Langley; Bruce Smith; Robyn McCall-Sani; Dan Levitt; Gary Van Nest; Daniel Gennevois; Joseph J Eiden
Journal:  Vaccine       Date:  2005-09-12       Impact factor: 3.641

2.  A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.

Authors:  J A Stoute; M Slaoui; D G Heppner; P Momin; K E Kester; P Desmons; B T Wellde; N Garçon; U Krzych; M Marchand
Journal:  N Engl J Med       Date:  1997-01-09       Impact factor: 91.245

3.  Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants.

Authors:  Salim Abdulla; Rolf Oberholzer; Omar Juma; Sulende Kubhoja; Francisca Machera; Christopher Membi; Said Omari; Alwisa Urassa; Hassan Mshinda; Ajuza Jumanne; Nahya Salim; Mwanjaa Shomari; Thomas Aebi; David M Schellenberg; Terrell Carter; Tonya Villafana; Marie-Ange Demoitié; Marie-Claude Dubois; Amanda Leach; Marc Lievens; Johan Vekemans; Joe Cohen; W Ripley Ballou; Marcel Tanner
Journal:  N Engl J Med       Date:  2008-12-08       Impact factor: 91.245

4.  Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.

Authors:  Philip Bejon; John Lusingu; Ally Olotu; Amanda Leach; Marc Lievens; Johan Vekemans; Salum Mshamu; Trudie Lang; Jayne Gould; Marie-Claude Dubois; Marie-Ange Demoitié; Jean-Francois Stallaert; Preeti Vansadia; Terrell Carter; Patricia Njuguna; Ken O Awuondo; Anangisye Malabeja; Omar Abdul; Samwel Gesase; Neema Mturi; Chris J Drakeley; Barbara Savarese; Tonya Villafana; W Ripley Ballou; Joe Cohen; Eleanor M Riley; Martha M Lemnge; Kevin Marsh; Lorenz von Seidlein
Journal:  N Engl J Med       Date:  2008-12-08       Impact factor: 91.245

5.  Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans.

Authors:  Troy D Querec; Rama S Akondy; Eva K Lee; Weiping Cao; Helder I Nakaya; Dirk Teuwen; Ali Pirani; Kim Gernert; Jiusheng Deng; Bruz Marzolf; Kathleen Kennedy; Haiyan Wu; Soumaya Bennouna; Herold Oluoch; Joseph Miller; Ricardo Z Vencio; Mark Mulligan; Alan Aderem; Rafi Ahmed; Bali Pulendran
Journal:  Nat Immunol       Date:  2008-11-23       Impact factor: 25.606

6.  Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses.

Authors:  Denis Gaucher; René Therrien; Nadia Kettaf; Bastian R Angermann; Geneviève Boucher; Abdelali Filali-Mouhim; Janice M Moser; Riyaz S Mehta; Donald R Drake; Erika Castro; Rama Akondy; Aline Rinfret; Bader Yassine-Diab; Elias A Said; Younes Chouikh; Mark J Cameron; Robert Clum; David Kelvin; Roland Somogyi; Larry D Greller; Robert S Balderas; Peter Wilkinson; Giuseppe Pantaleo; Jim Tartaglia; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  J Exp Med       Date:  2008-12-01       Impact factor: 14.307

7.  Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity.

Authors:  Troy Querec; Soumaya Bennouna; Sefik Alkan; Yasmina Laouar; Keith Gorden; Richard Flavell; Shizuo Akira; Rafi Ahmed; Bali Pulendran
Journal:  J Exp Med       Date:  2006-02-06       Impact factor: 14.307
  7 in total
  13 in total

1.  Pharmacologic induction of CD8+ T cell memory: better living through chemistry.

Authors:  Luca Gattinoni; Christopher A Klebanoff; Nicholas P Restifo
Journal:  Sci Transl Med       Date:  2009-12-16       Impact factor: 17.956

2.  Institute of Medicine calls for savvier vaccine strategy.

Authors:  Charlotte Schubert
Journal:  Nat Med       Date:  2010-01       Impact factor: 53.440

3.  TLR, NLR Agonists, and Other Immune Modulators as Infectious Disease Vaccine Adjuvants.

Authors:  Sarah C Higgins; Kingston H G Mills
Journal:  Curr Infect Dis Rep       Date:  2010-01       Impact factor: 3.725

Review 4.  Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.

Authors:  David H Cribbs
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-04       Impact factor: 4.388

5.  Study of matrix additives for sensitive analysis of lipid A by matrix-assisted laser desorption ionization mass spectrometry.

Authors:  Ping Zhou; Eleonora Altman; Malcolm B Perry; Jianjun Li
Journal:  Appl Environ Microbiol       Date:  2010-04-09       Impact factor: 4.792

6.  Enzymatic stability and immunoregulatory efficacy of a synthetic indolicidin analogue with regular enantiomeric sequence.

Authors:  Ching-Yun Chang; Chih-Wei Lin; Sheng-Kuo Chiang; Po-Ling Chen; Chiung-Yi Huang; Shih-Jen Liu; Pele Chong; Ming-Hsi Huang
Journal:  ACS Med Chem Lett       Date:  2013-04-24       Impact factor: 4.345

7.  Micrometer-sized titanium particles can induce potent Th2-type responses through TLR4-independent pathways.

Authors:  Pankaj K Mishra; Wenhui Wu; Cristina Rozo; Nadim J Hallab; Joseph Benevenia; William C Gause
Journal:  J Immunol       Date:  2011-11-16       Impact factor: 5.422

8.  Emulsified nanoparticles containing inactivated influenza virus and CpG oligodeoxynucleotides critically influences the host immune responses in mice.

Authors:  Ming-Hsi Huang; Su-Chen Lin; Chia-Hsin Hsiao; Hsin-Ju Chao; Hung-Ren Yang; Chien-Chun Liao; Po-Wei Chuang; Huang-Pi Wu; Chiung-Yi Huang; Chih-Hsiang Leng; Shih-Jen Liu; Hsin-Wei Chen; Ai-Hsiang Chou; Alan Yung-Chih Hu; Pele Chong
Journal:  PLoS One       Date:  2010-08-19       Impact factor: 3.240

9.  The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirus.

Authors:  Simone C de Cassan; Emily K Forbes; Alexander D Douglas; Anita Milicic; Bijender Singh; Puneet Gupta; Virander S Chauhan; Chetan E Chitnis; Sarah C Gilbert; Adrian V S Hill; Simon J Draper
Journal:  J Immunol       Date:  2011-08-03       Impact factor: 5.422

10.  Adjuvant effect of docetaxel on the immune responses to influenza A H1N1 vaccine in mice.

Authors:  Jian Chen; Lin Yuan; Qing Fan; Fei Su; Yu Chen; Songhua Hu
Journal:  BMC Immunol       Date:  2012-07-07       Impact factor: 3.615
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.